|
1
|
Llovet JM, Schwartz M and Mazzaferro V:
Resection and liver transplantation for hepatocellular carcinoma.
Semin Liver Dis. 25:181–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grazi GL, Ercolani G, Pierangeli F, Del
Gaudio M, Cescon M, Cavallari A and Mazziotti A: Improved results
of liver resection for hepatocellular carcinoma on cirrhosis give
the procedure added value. Ann Surg. 234:71–78. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
Global Cancer Statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Desjardins LA: Hepatocellular carcinoma.
Clin J Oncol Nurs. 6:107–108. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Yao M, Dong Z, Zhang Y and Yao D:
Circulating specific biomarkers in diagnosis of hepatocellular
carcinoma and its metastasis monitoring. Tumour Biol. 35:9–20.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Contratto M and Wu J: Targeted therapy or
immunotherapy? Optimal treatment in hepatocellular carcinoma. World
J Gastrointest Oncol. 10:1082018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji F, Fu SJ, Shen SL, Zhang LJ, Cao QH, Li
SQ, Peng BG, Liang LJ and Hua YP: The prognostic value of combined
TGF-β1 and ELF in hepatocellular carcinoma. BMC Cancer. 15:1162015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ng KK, Lo CM, Liu CL, Poon RT, Chan SC and
Fan ST: Survival analysis of patients with transplantable recurrent
hepatocellular carcinoma: Implications for salvage liver
transplant. Arch Surg. 143:68–74. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim DY, Paik YH, Ahn SH, Youn YJ, Choi JW,
Kim JK, Lee KS, Chon CY and Han KH: PIVKA-II is a useful tumor
marker for recurrent hepatocellular carcinoma after surgical
resection. Oncology. 72 (Suppl 1):52–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu SJ, Qi CY, Xiao WK, Li SQ, Peng BG and
Liang LJ: Glypican-3 is a potential prognostic biomarker for
hepatocellular carcinoma after curative resection. Surgery.
154:536–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Y, Liang X, Lu M, Weng T, Liu Y and Ye
X: Mammalian target of rapamycin as a novel target in the treatment
of hepatocellular carcinoma. Hepatogastroenterology. 57:913–918.
2010.PubMed/NCBI
|
|
16
|
Marrero JA, Feng Z, Wang Y, Nguyen MH,
Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D,
et al: Alpha-fetoprotein, des-gamma carboxyprothrombin, and
lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
Gastroenterology. 137:110–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cristea CG, Gheonea IA, Săndulescu LD,
Gheonea DI, Ciurea T and Purcarea MR: Considerations regarding
current diagnosis and prognosis of hepatocellular carcinoma. J Med
Life. 8:120–128. 2015.PubMed/NCBI
|
|
18
|
Xie ZH, Yu J, Shang L, Zhu YQ, Hao JJ, Cai
Y, Xu X, Zhang Y and Wang MR: KIAA1522 overexpression promotes
tumorigenicity and metastasis of esophageal cancer cells through
potentiating the ERK activity. Onco Targets Ther. 10:3743–3754.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Cheung ST, So S, Fan ST, Barry C,
Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al: Gene expression
patterns in human liver cancers. Mol Biol Cell. 13:1929–1939. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th Edition of theAJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maiolino P, Restucci B, Papparella S,
Paciello O and De Vico G: Correlation of nuclear morphometric
features with animal and Human World Health Organization
international histological classifications of canine spontaneous
seminomas. Vet Pathol. 41:608–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Durand FO and Valla D: Assessment of the
prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 42
(Suppl):S100–S107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Franssen B, Alshebeeb K, Tabrizian P,
Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S and Schwartz
ME: Differences in surgical outcomes between hepatitis B- and
hepatitis C-related hepatocellular carcinoma: A retrospective
analysis of a single North American center. Ann Surg. 260:650–658.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu CQ, Ding K, Strumpf D, Weir BA,
Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, et
al: Prognostic and predictive gene signature for adjuvant
chemotherapy in resected non-small-cell lung cancer. J Clin Oncol.
28:4417–4424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu CQ, Pintilie M, John T, Strumpf D,
Shepherd FA, Der SD, Jurisica I and Tsao MS: Understanding
prognostic gene expression signatures in lung cancer. Clin Lung
Cancer. 10:331–340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagase T, Kikuno R, Ishikawa K, Hirosawa M
and Ohara O: Prediction of the coding sequences of unidentified
human genes. XVII. The Complete Sequences of 100 New cDNA clones
from brain which code for large proteins in vitro. DNA Res.
7:143–150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Wang Y, Fan H, Zhang Z and Li N:
miR-125b-5p inhibits breast cancer cell proliferation, migration
and invasion by targeting KIAA1522. Biochem Biophys Res Commun.
504:277–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu YZ, Yang H, Cao J, Jiang YY, Hao JJ,
Xu X, Cai Y and Wang MR: KIAA1522 is a novel prognostic biomarker
in patients with non-small cell lung cancer. Sci Rep. 6:247862016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takamoto T, Sano K, Hashimoto T, Ichida A,
Shimada K, Maruyama Y and Makuuchi M: Practical contribution of
virtual hepatectomy for colorectal liver metastases: A
propensity-matched analysis of clinical outcome. J Gastrointest
Surg. 22:2037–2044. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou XD, Tang ZY, Ma ZC, Fan J, Wu ZQ, Qin
LX, Zhou J, Yu Y, Sun HC and Qiu SJ: Twenty-year survivors after
resection for hepatocellular carcinoma-analysis of 53 cases. J
Cancer Res Clin Oncol. 135:1067–1072. View Article : Google Scholar : PubMed/NCBI
|
